Close metadata

Recommended articles:

Features of the clinical picture of affective disorders in women during the menopausal transition and early postmenopause. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):75-79

Associations of serum neuromarkers with clinical features of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):145-152

Prevalence of cognitive impairment in older adults in the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11

Cognitive impairment in cerebrovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16

Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer’s disease and vascular cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):17-24

EEG changes in patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):72-76

Drug-induced cognitive impairment and dementia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):77-85

Cognitive impairment in multiple system atrophy — exclusion criteria or an integral part of the clinical picture?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):86-91

Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30

Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137

Authors:

Torshin I.Iu.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna

Gusev E.I.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta, Moskva

RSCI AuthorID: 91278
Scopus AuthorID: 35599379800
ORCID: 0000-0003-0742-6875

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

ORCID: 0000-0002-7663-710X

Kalacheva A.G.

Ivanovo State Medical Academy, Ministry of Health of Russia

Rudakov K.V.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO

List of references:

VIDAL'. Spravochnik lekarstvennykh sredstv. AstroMedServis 2011; 1254.
Gromova O.A., Torshin I.Yu., Egorova E.Yu. "Umnye" mikronutrienty i nervno-psikhicheskoe razvitie rebenka. M: Miklosh 2011; 230.
Zhuravlev Yu.I. Ob algebraicheskom podkhode k resheniyu zadach raspoznavaniya ili klassifikatsii. Problemy kibernetiki. M: Nauka 1978; 33: 5-68.
Rudakov K.V. Universal'nye i lokal'nye ogranicheniya v probleme korrektsii evristicheskikh algoritmov. Kibernetika 1987; 2: 30-35.
Rudakov K.V., Torshin I.Yu. Voprosy razreshimosti zadachi raspoznavaniya vtorichnoi struktury belka. Informatika i ee primeneniya 2010; 4: 2: 25-35.
Rudakov K.V. O problemakh klassifikatsii znachenii priznakov v zadachakh raspoznavaniya. "Intellektualizatsiya obrabotki informatsii" (IOI-8). Kipr, Pafos, 17-23 oktyabrya 2010.
Gromova O.A., Torshin I.Yu., Rudakov K.V., Gusev E.I. Krupnomasshtabnye klinicheskie issledovaniya omega-3 PNZhK. Serdtse 2011; 5.
Torshin I.Yu., Gromova O.A., Egorova E.Yu., Rudakov K.V. Sistematicheskii analiz molekulyarnykh mekhanizmov vozdeistviya omega-3 na aritmiyu. Kardiologiya 2011; 5: 7-11.
Torshin I.Yu., Gromova O.A. Dvadtsat' pyat' mgnovenii molekulyarnoi farmakologii. A-Grif 2011; 560.
Amin A.A., Menon R.A., Reid K.J. et al. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom Med 2008; 70: 8: 856-862.
Astarita G., Jung K.M., Berchtold N.C. et al. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS One 2010; 5: 9: 12538.
Baghai T.C., Varallo-Bedarida G., Born C. et al. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 index. J Clin Psychiatry 2010.
Bazan N.G. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 2003; 44: 12: 2221-2233.
Bazan N.G. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 2007; 10: 2: 136-141.
Begin M.E., Plourde M., Pifferi F., Cunnane S.C. What Is the Link between Docosahexaenoic Acid, Cognitive Impairment, and Alzheimer's Disease in the Elderly? Frontiers in Neuroscience, Chapter 19, ISBN- 9781420067750, CRC Press 2011.
Beydoun M.A., Kaufman J.S., Sloane P.D. et al. N-3 fatty acids, hypertension and risk of cognitive decline among older adults in the ARIC study. Public Health Nutr 2008; 11: 1: 17-29.
Cherubini A., Andres-Lacueva C., Martin A. et al. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007; 62: 10: 1120-1126.
Colangelo L.A., He K., Whooley M.A. et al. Higher dietary intake of long-chain omega-3 is inversely associated with depressive symptoms in women. Nutrition 2009; 25: 10: 1011-1019.
Cole G.M., Frautschy S.A. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr Health 2006; 18: 3: 249-259.
Dinan T., Siggins L., Scully P. et al. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res 2009; 43: 471-476.
Dullemeijer C., Durga J., Brouwer I.A. et al. n-3 fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr 2007; 86: 5: 1479-1485.
Dullemeijer C., Verhoef P., Brouwer I.A. et al. Plasma very long-chain n-3 polyunsaturated fatty acids and age-related hearing loss in older adults. J Nutr Health Aging 2010; 14: 5: 347-351.
Dyall S.C., Michael G.J., Michael-Titus A.T. Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. J Neurosci Res 2010; 88: 10: 2091-2102.
Fritsche K. Fatty acids as modulators of the immune response. Annu Rev Nutr 2006; 26: 45-73.
Gao Q., Niti M., Feng L. et al. Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies. J Nutr Health Aging 2011; 15: 1: 32-35.
Gillette Guyonnet S., Abellan Van Kan G. et al. IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 2007; 11: 132-152.
Golding J., Steer C., Emmett P. et al. High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 2009; 20: 4: 598-603.
Gonzalez-Gross M., Marcos A., Pietrzik K. Nutrition and cognitive impairment in the elderly. Br J Nutr 2001; 86: 313-321.
Grant W.B. Dietary links to Alzheimer's disease: 1999 update. J Alzheimer's Dis 1999; 1: 197-201.
Hedelin M., Lof M., Olsson M. et al. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population. BMC Psychiatry 2010; 10: 38.
Iamandei G.L., Mocanu V., Luca V. Omega-3 fatty acids and acetylcysteine diet supplementation effects on learning performance. Rev Med Chir Soc Med Nat Iasi 2010; 114: 3: 808-812.
Kesse-Guyot E., Peneau S., Ferry M. et al. Thirteen-year prospective study between fish consumption, long-chain n-3 fatty acids intakes and cognitive function. J Nutr Health Aging 2011; 15: 2: 115-120.
Kraguljac N.V., Montori V.M., Pavuluri M. et al. Efficacy of omega-3 Fatty acids in mood disorders - a systematic review and metaanalysis. Psychopharmacol Bull 2009; 42: 3: 39-54.
Lesperance F., Frasure-Smith N., St-Andre E. et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry 2010.
Lin P.Y., Huang S.Y., Su K.P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010; 68: 2: 140-147.
Lopez L.B., Kritz-Silverstein D., Barrett Connor E. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo study. J Nutr Health Aging 2011; 15: 1: 25-31.
Maes M., Mihaylova I., Kubera M., Bosmans E. Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response. Neuro Endocrinol Lett 2007; 28: 6: 875-880.
Mamalakis G., Tornaritis M., Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 5: 311-318.
McNamara R.K., Jandacek R., Rider T. et al. Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot Essent Fatty Acids 2010; 83: 4-6: 185-191.
Menard C., Patenaude C., Gagne A.M., Massicotte G. AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures. J Neurosci Res 2009; 87: 4: 876-886.
Messamore E., Hoffman W.F., Yao J.K. Niacin sensitivity and the arachidonic acid pathway in schizophrenia. Schizophr Res 2010; 122: 1-3: 248-256.
Milte C.M., Sinn N., Street S.J. et al. Erythrocyte polyunsaturated fatty acid status, memory, cognition and mood in older adults with mild cognitive impairment and healthy controls. Prostaglandins Leukot Essent Fatty Acids 2011; 84: 5-6: 153-161.
Morris M.C., Evans D.A., Bienias J.L. et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60: 7: 940-946.
Mukherjee P.K., Chawla A., Loayza M.S., Bazan N.G. Docosanoids are multifunctional regulators of neural cell integrity and fate. Prostaglandins Leukot Essent Fatty Acids 2007; 77: 5-6: 233-238.
Muldoon M.F., Ryan C.M., Sheu L. et al. Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood. J Nutr 2010; 140: 4: 848-853.
Murakami K., Miyake Y., Sasaki S. et al. Fish and n-3 polyunsaturated fatty acid intake and depressive symptoms: Ryukyus Child Health Study. Pediatrics 2010; 126: 3: 623-630.
Roberts R.O., Cerhan J.R., Geda Y.E. et al. Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging. J Alzheimers Dis 2010; 21: 3: 853-865.
Rosenberg I.H., Miller J.W. Nutritional factors in physical and cognitive functions of elderly people. Am J Clin Nutr 1992; 55: 1237-1243.
Sanchez Munoz-Torrero J.F., Munoz J., Caparros G., Martinez-Ara G. Lupus nephropathy with positive syphilis serology. An Med Interna 1990; 7: 12: 651-652.
Sanchez-Villegas A., Henriquez P., Figueiras A. et al. Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr 2007; 46: 6: 337-346.
Sanchez-Villegas A., Verberne L., De Irala J. et al. Dietary fat intake and the risk of depression. PLoS One 2011; 6: 1: 16268.
Schaefer E.J., Bongard V., Beiser A.S. et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease. Arch Neurol 2006; 63: 1545-1550.
Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8: 5: 349-361.
Sontrop J., Avison W.R., Evers S.E. et al. Depressive symptoms during pregnancy in relation to fish consumption and intake of n-3 polyunsaturated fatty acids. Paediatr Perinat Epidemiol 2008; 22: 389-399.
Su K.P., Huang S.Y., Chiu T.H. et al. Omega-3 fatty acids for major depressive disorder during pregnancy. J Clin Psychiatry 2008; 69: 4: 644-651.
Su K.P. Biological mechanism of antidepressant effect of omega-3. Neurosignals 2009; 17: 144-152.
Torshin I.Yu. Bioinformatics in the post-genomic era: physiology and medicine. ISBN 9781600 217524. Nova Biomedical 2007; 300.
Torshin I.Yu. Bioinformatics in the post-genomic era: sensing the change from molecular genetics to personalized medicine. Nova Biomedical Books, NY, USA 2009. In "Bioinformatics in the Post-Genomic Era" series, ISBN: 978-1-60692-217-0.
Wada M., DeLong C.J., Hong Y.H. et al. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 2007; 282: 31: 22254-22266.
Yurko-Mauro K., McCarthy D., Rom D. et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 2010; 6: 6: 456-464.
Yurko-Mauro K. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res 2010; 7: 3: 190-196.

Close metadata